SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Rei Ohnishi, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Kyogo Itoh, A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time, BMC Cancer, 2013, 13, 1, 613

    CrossRef

  2. 2
    Akira Yamada, Tetsuro Sasada, Masanori Noguchi, Kyogo Itoh, Next-generation peptide vaccines for advanced cancer, Cancer Science, 2013, 104, 1
  3. 3
    Masanori Noguchi, Tetsuro Sasada, Kyogo Itoh, Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine, Cancer Immunology, Immunotherapy, 2013, 62, 5, 919

    CrossRef

  4. 4
    Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Kei Matsuoka, Gaku Arai, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Kyogo Itoh, Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy, The Prostate, 2012, 72, 8
  5. 5
    Erika Vacchelli, Isabelle Martins, Alexander Eggermont, Wolf Hervé Fridman, Jerome Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial watch, OncoImmunology, 2012, 1, 9, 1557

    CrossRef

  6. 6
    Wei Xu, Hui-Zhong Li, Jun-Jie Liu, Zhen Guo, Bao-Fu Zhang, Fei-Fei Chen, Dong-Sheng Pei, Jun-Nian Zheng, Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen, Tumor Biology, 2011, 32, 1, 63

    CrossRef

  7. You have full text access to this Open Access content7
    Hirotsugu Uemura, Kiyohide Fujimoto, Takashi Mine, Shigeya Uejima, Marco A. De Velasco, Yoshihiko Hirao, Nobukazu Komatsu, Akira Yamada, Kyogo Itoh, Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer, Cancer Science, 2010, 101, 3
  8. 8
    Masanori Noguchi, Personalized peptide vaccination for urological cancer, Drug Delivery System, 2010, 25, 2, 103

    CrossRef

  9. 9
    Masayasu Naito, Kyogo Itoh, Nobukazu Komatsu, Yuichi Yamashita, Takafumi Shirakusa, Akira Yamada, Fukuko Moriya, Hitoshi Ayatuka, Elnisr Rashed Mohamed, Kei Matsuoka, Masanori Noguchi, Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients, The Prostate, 2008, 68, 16
  10. 10
    Yoshihiro Oka, Akihiro Tsuboi, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama, WT1 peptide vaccine for the treatment of cancer, Current Opinion in Immunology, 2008, 20, 2, 211

    CrossRef

  11. 11
    Elena N. Klyushnenkova, Diana V. Kouiavskaia, James A. Kodak, Arthur A. Vandenbark, Richard B. Alexander, Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase, The Prostate, 2007, 67, 10
  12. 12
    Masanori Noguchi, Akihisa Yao, Mamoru Harada, Osamu Nakashima, Yoshihiro Komohara, Satoko Yamada, Kyogo Itoh, Kei Matsuoka, Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer, The Prostate, 2007, 67, 9
  13. 13
    A.K. Thomas-Kaskel, H. Veelken, Inmunoterapia activa en cáncer de próstata: Revisión con atención especial a las células dendríticas, Actas Urológicas Españolas, 2007, 31, 6, 668

    CrossRef

  14. 14
    Andrea Marrari, Manuela Iero, Lorenzo Pilla, Sergio Villa, Roberto Salvioni, Riccardo Valdagni, Giorgio Parmiani, Licia Rivoltini, Vaccination therapy in prostate cancer, Cancer Immunology, Immunotherapy, 2007, 56, 4, 429

    CrossRef

  15. 15
    Kyogo Itoh, Akira Yamada, Personalized peptide vaccines: A new therapeutic modality for cancer, Cancer Science, 2006, 97, 10
  16. 16
    Masanori Noguchi, Kyogo Itoh, Akihisa Yao, Takashi Mine, Akira Yamada, Yayoi Obata, Masatoshi Furuta, Mamoru Harada, Shigetaka Suekane, Kei Matsuoka, Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients, The Prostate, 2005, 63, 1
  17. 17
    Johannes Vieweg, Jens Dannull, Technology Insight: vaccine therapy for prostate cancer, Nature Clinical Practice Urology, 2005, 2, 1, 44

    CrossRef

  18. 18
    Yutaka Kawakami, Tomonobu Fujita, Yuriko Matsuzaki, Toshiharu Sakurai, Makoto Tsukamoto, Masahiro Toda, Hidetoshi Sumimoto, Identification of human tumor antigens and its implications for diagnosis and treatment of cancer, Cancer Science, 2004, 95, 10